News for Healthier Living

Artesunate Targets GBA To Trigger Apoptosis In Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) remains a highly prevalent malignancy worldwide with limited therapeutic options and frequent resistance to treatment, necessitating the development of targeted pharmacological interventions. Although artesunate, a derivative of the widely used antimalarial drug artemisinin, has emerged as a promising anticancer candidate, the molecular basis underlying its antitumor activity in HCC has remained unclear.

August 18, 2026


August 18 2026

August 17 2026

August 16 2026

August 15 2026

August 14 2026

August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026